Drug search by name
Insulin degludec and liraglutide Subcutaneous and Panitumumab
Determining the interaction of Insulin degludec and liraglutide Subcutaneous and Panitumumab and the possibility of their joint administration.
Check result:
Insulin degludec and liraglutide Subcutaneous <> Panitumumab
Relevance: 09.07.2022
Reviewer: Shkutko P.M., M.D., in
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Insulin degludec and liraglutide Subcutaneous
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Insulin degludec and liraglutide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
The list of popular interactions
- Insulin degludec and liraglutide Subcutaneous-Panitumumab Intravenous
- Insulin degludec and liraglutide Subcutaneous-Panixine
- Insulin degludec and liraglutide Subcutaneous-Panixine DisperDose
- Insulin degludec and liraglutide Subcutaneous-Panlor
- Insulin degludec and liraglutide Subcutaneous-Panlor Tablet
- Insulin degludec and liraglutide Subcutaneous-Panlor Tablets
- Panitumumab-Insulin degludec Subcutaneous
- Panitumumab-Insulin detemir
- Panitumumab-Insulin Detemir (Cartridges and Prefilled Syringes)
- Panitumumab-Insulin Detemir (Vials)
- Panitumumab-Insulin detemir Subcutaneous
- Panitumumab-Insulin glargine
Doktika World
Interaction with food and lifestyle
Disease interaction